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Abstract
Background:  Alternative exons encode different isoforms of the human insulin-like growth
factor-I (IGF-I) precursor without altering mature IGF-I. We hypothesized that the various IGF-I
precursors may traffic IGF-I differently. Chimeric IGF-I precursors were made with green
fluorescent protein (GFP) cloned between the signal and mature IGF-I domains.
Results: Chimeras containing exons 1 or 2 were located in the cytoplasm, consistent with a
secretory pathway, and suggesting that both exons encoded functional signal peptides. Exon 5-
containing chimeras localized to the nucleus and strongly to the nucleolus, while chimeras
containing exon 6 or the upstream portion of exon 5 did not. Nuclear and nucleolar localization
also occurred when the mature IGF-I domain was deleted from the chimeras, or when signal
peptides were deleted.
Conclusions: We have identified a nucleolar localization for an isoform of the human IGF-I
precursor. The findings are consistent with the presence of a nuclear and nucleolar localization
signal situated in the C-terminal part of the exon 5-encoded domain with similarities to signals in
several other growth factors.
Background
Most human genes contain introns, which must be ex-
cised for correct gene expression. A substantial number of
genes are alternatively spliced, generating a great number
of protein isoforms [1]. In some cases, experimental evi-
dence has been accrued for distinct function, but most
variant isoforms have not been fully characterized. Hu-
man IGF-I is a 70 amino acid residue peptide with growth
promoting and metabolic actions. Four of the six exons of
the human IGF-I gene are alternatively spliced (Fig. 1A).
The alternative splices encode different precursor pep-
tides. Exons 1 and 2 are alternative leader exons derived
from different transcription start sites, and encode part of
the signal peptide [2,3]. The variant N-terminal domains
encoded by IGF-I exons 1 or 2 are processed by canine mi-
crosomes, suggesting both are functional signal peptides
[4]. Parts of exons 3 and 4 encode the mature IGF-I pep-
tide and are constant. Alternative exons 5 and 6 encode
different E domains. Part of the E domain encoded by
exon 5 contains an amidated growth-promoting peptide
[5], but there are little other functional data [6]. Despite
the lack of experimental data on functional significance of
the isoforms, there is conservation of the genomic archi-
tecture of the exons, the splicing patterns producing alter-
native isoforms [3], and the peptide sequences (Fig. 1B).
In this work we investigated the localization of alternative
precursors of IGF-I to see if their cellular trafficking dif-
fered. We found one isoform that localized to the nucleo-
lus and mapped the domains required for such
localization.
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Results
IGF-I fusion proteins have distinct intracellular localization
The IGF-I chimeras used GFP as a fluorescent reporter
(Fig. 2). The two signal peptides, MGKIS (exon 1 and 5'
part of exon 3) and MITP (exon 2 and 5' part of exon 3),
were fused to the N-terminal of GFP, while the B, C, A and
variant E domains of IGF-I were fused to the C-terminal of
GFP. This resulted in the expression of four different fu-
sions: 1-G-3-4-6; 2-G-3-4-6; 1-G-3-4-5; and 2-G-3-4-5.
When the constructions were expressed in cultured Hela
cells, both signal peptides committed the GFP fluores-
cence to a cytoplasmic structures, consistent with the se-
cretory apparatus (Fig. 3). However, a mixed localization
pattern was seen for fusions containing the Eb-encoding
exon 5, with a reproducible fluorescence seen in the nu-
cleus and strongly in the nucleolus (Fig. 3). Such localiza-
tions were seen in multiple cells, in many independent
transfections, with Hela cells from several sources, after
shorter times of over-expression, after calcium phosphate
and electroporation methods, and there was no correla-
tion between levels of expression and localization (data
not shown). Co-localization studies were performed us-
Figure 1
(A) Alternative splicing of the human IGF-I gene. Exons are shown as boxes, introns as lines, transcription start sites as arrows,
splicing patterns as sloped lines, and polyadenylation signals as the letter A. The protein coding potential of the exons is indi-
cated underneath. (B) Alignment of predicted alternative E domains. Species are given on the left; non-homologous residues
are highlighted in yellow; similarities are underlined.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/17
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ing an anti-nucleolus monoclonal antibody and con-
firmed the localization as being nucleolar (Fig. 4).
A nucleolar localization signal in the Eb domain
To test the role of IGF-I domains in the nuclear and nucle-
olar localization, chimeras were constructed that deleted
part of exon 3 encoding the B and C domains (2-G-4-5
and 1-G-4-5). The clear nuclear and nucleolar localization
remained when the 2-G-4-5 construction was overex-
pressed (Fig. 5A). However, in the case of the 1-G-4-5 con-
struction, the fluorescence was rapidly exported, and little
nuclear or nucleolar localization was seen. We interpret
this as an effect of the strength of the secretory signal pep-
tide in competition with the nuclear and nucleolar locali-
zation signal(s). To exclude the possibility that the exon 2-
encoded signal peptide was directly involved in the nucle-
ar and nucleolar localization, it was deleted from the con-
struction to make G-4-5, which still had a nuclear and
nucleolar localization (Fig. 5A). To test the part of the Eb
domain with this property, a naturally occurring splice
variant, Ec, was used. This splice consists of the 5' portion
of exon 5, encoding the N-terminal part of the Eb domain,
and then splices to exon 6 [7]. This fusion (G-4-5-6) locat-
ed throughout the cell, in a diffuse pattern, both in the nu-
cleus and cytoplasm, without the striking nucleolar
localization (Figure 5A). These data are consistent with
the presence of a nucleolar localization signal at the C-ter-
minal of the Eb domain.
The E peptides are not cleaved intracellularly
We performed western blotting on lysates from transfect-
ed cells (Fig. 5B). The size of the band for G-4-5 (lane 2)
was larger than G-4-5-6 (lane 3), while G-4-6 (lane 4) was
the smallest. This is compatible with the different sizes of
the E domains and shows that the E domains are not
cleaved intracellularly. This is despite the presence of pre-
viously mapped [8] prohormone processing sites and
flanking residues in the chimeric proteins. However, the
signal peptides appear to be cleaved, as 1-G-4-5 and 2-G-
4-5 gave a band of the same size as G-4-5 (compare lanes
5 and 6 to lane 2). Note the band for 1-G-4-5 was faint on
this exposure due to some degradation, but was better
seen on overexposed blots (not shown).
Discussion
Using GFP-fusions, we found that the IGF-I exon 5-encod-
ed Eb domain localized chimeric proteins to the nucleus
and nucleolus. The localization did not require the signal
peptides, mature peptide or the N-terminal part of the Eb
peptide. The last four amino acid residues of the Eb do-
main matches the motif R/K-R/K-X-R/K which is found in
several nucleolar localization signals [9]. The presence of
the chimeric IGF-I precursors in the nucleus and nucleolus
was not an artefact of over-expression since it was seen in
cells with varying expression levels and at shorter times af-
ter transfection. It is unlikely that this localization was an
artefact of tagging because of the consistent pattern seen
in different chimeric contexts. Nuclear and nucleolar lo-
calization were seen more in the context of the exon 2-en-
coded, rather than the exon 1-encoded signal peptide, but
the signal peptide itself was not required for such localiza-
tion. This may reflect an indirect action of the signal pep-
tide. Thus, there may be a relative weakness of secretory
function for the exon 2-encoded signal peptide compared
to that encoded by exon 1. Our data suggest that the signal
peptides were efficiently cleaved from the chimeras. The
Eb domain was not cleaved from the chimeric precursor
IGF-I, and we propose that any biological activity in the
nucleolus may be a property of pro-IGF-I. The final loca-
tion of the chimeras may represent a balance of the com-
petition between secretory and nuclear/nucleolar
localization signals.
Figure 2
GFP-IGF-I chimeras. The designations of the chimeras are on
the left, while the domain structures of the chimeras are
shown only approximately to scale. The first and last amino
acid residue of each domain is given underneath, while the
numbers are the coordinates relative to the first residue of
the mature IGF-I peptide, a glycine.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/17
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The nucleolus is a membrane-less dynamic structure or-
ganized by transcription and disassembled during mitosis
[10]. There are a number of examples of nucleolar locali-
zation of growth factors [11]. A well-characterized exam-
ple is fibroblast growth factor-3, where two nuclear and
one nucleolar localization signals act in concert [12] and
in competition with secretory signals [13], with an inhib-
itory action on cell growth [14]. Recently a nucleolar
binding protein for fibroblast growth factor-3, NoBP, has
been isolated and characterized [15]. A question is wheth-
er other nucleolar growth factors also interact with NoBP,
or whether they interact through distinct proteins. The nu-
cleolus has multiple functions, including ribosome syn-
thesis, signal recognition particle processing and
assembly, and processing of U6 snRNP, snoRNAs, telom-
erase RNA and tRNAs [16]. The nucleolus is a key site in
the regulation of the oncogenic p53-Mdm2-ARF pathway
[9]. It is not clear how an isoform of the IGF-I may affect
any of these nucleolar functions.
Conclusions
We found that the isoform of the human IGF-I precursor
encoded by exon 5 localized to the nucleus and strongly
to the nucleolus. Precursors containing exon 6 or the up-
stream portion of exon 5 did not. Nuclear and nucleolar
localization also occurred when the mature IGF-I domain
was deleted from the chimeras, or when signal peptides
were deleted. The findings are consistent with the pres-
ence of a nuclear and nucleolar localization signal situat-
ed in the C-terminal part of the exon 5-encoded domain.
These findings are similar to the localization of several
other growth factors in the nucleolus.
Materials and methods
Construction of chimeric proteins
The chimeric constructions are shown in Fig. 2. Coordi-
nates are given relative to the N-terminal residue (G) of
the mature IGF-I peptide. IGF-I exon 1 encodes part of a
signal peptide from residues MGK [-48 to -46] to K [-28].
Exon 3 encodes the remainder of the signal peptide from
residues VKM [-27 to -25] to A [-1]. This was cloned up-
stream of the cDNA for GFP. Exon 3 encodes the mature
IGF-I peptide starting at residues GPET [1–4] to F [25],
exon 4 encodes the mature IGF-I peptide from residue N
[26] to A [70] and part of the E domain from residues RSV
[71–73] to K [86]. Exon 6 encodes an alternative Ea do-
main starting at residues FVH [87–89] to M [105]. This
IGF-I cDNA sequence is from Genbank X57025 [2]. In
other chimeras, exon 2 replaces exon 1 and encodes the
residues MITPT [-32 to -28]. The sequence is from Gen-
bank M37484 [3]. Exon 5 encodes an alternative Eb do-
main starting at residues YDP [87–89] to K [148]. This
sequence is from Genbank M11568 [17]. Exon 5–6 en-
codes the alternative Ec domain, beginning with exon 5-
encoded residues YDP [87–89] to K [102], then ending in
the exon 6-encoded residues GMTFEERK [103 to 110].
This sequence is from Genbank U40870 [7].
Signal peptides were made by PCR using primers AgeI-
IGF-MGKISS (5'-GGCTACCGGTCTTCAGAAGCAAT-
GGGAA) or AgeI-IGF-MITP (5'-GGCTACCGGTATGATTA-
CACCTACAGTGAA) with AgeI-IGF-SPA (5'-
GGCTACCGGTCCAGCCGTGGCAGA) and cloned into
the AgeI site of pEGFP-C1. This cloning strategy introduc-
es four amino acid residues (PVAT) between the last resi-
due A [-1] of the signal peptide and the first residue of
GFP. The mature IGF-I and Ea, or Eb or Ec domains were
generated by PCR using primers Eco-GPETLC (5'-GGAAT-
TCCGGACCGGAGACGCTCTGC) and Sac-E6-650A (5'-
GCTGAGCCGCGGTTCACTCCTCAGGAGGGTCTT) or
Sac-E5-543A (5'-GCTGAGCCGCGGTTTAATCCTCCT-
GTCCTTCA) or SacII-E6-619A (5'-GCTGAGCCGCGGG-
TAGTTCTTGTTTCCTGC). The PCR products were cloned
into the EcoRI and SacII sites in pEGFP-C1. The chimeras
with IGF-I exon 3 deletions were made using the primer
EcoRI-MOD4-2244S (5'-GGAATTCCGGGTATGGCTC-
CAGCAGT) resulting in fusions between GFP and IGF-I
from residues GYG [30–32]. EcoRI and SacII cloning sites
Figure 3
Localization of full-length chimeric proteins. The field were
imaged by phase contrast (left column) or fluorescence (right
column) microscopy. The identity of the chimeras is given on
the left.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/17
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in pEGFP-C1 were used. All PCR products were made by
proof-reading PCR using Pfu Turbo (Stratagene) and all
clones were verified by sequencing.
Transfections, cell imaging and western blotting
2 ug of each plasmid was transfected into Hela cells cul-
tured on coverslips in 3 cm wells using 94 ul of Fugene 6
(Boehringer). After 12–24 hours of expression, cells were
incubated at room temperature for one hour and fixed in
2% w/v paraformaldehyde. Cells subjected to immun-
ofluorescence were washed in PBS, permeabilized with
Figure 4
Nucleolar localization of chimera containing exon 5. Fluores-
cence microscopy of Hela cells expressing the chimera and a
specific nucleolar antigen detected with an anti-nucleolus
antibody. The images were merged electronically and yellow
indicates co-localization.
Figure 5
(A) The mature IGF-I domain is not required for nucleolar
localization, while replacing the C-terminal part of the E
domain encoded by exon 5 results in loss of specific nucleo-
lar localization. The left panels are phase images except for 2-
G-4-5 which was saved as a pseudo-DIC image instead. (B)
Western blot of lysates from transfected cells using an anti-
GFP antibody. The identity of the transfected chimera is
given above the lanes. Positions of the size markers are given
on the left.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/17
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0.2% v/v Triton X100 in 1% v/v normal goat serum, be-
fore incubation with an anti-human nucleolus mono-
clonal antibody (Calbiochem). After washes in 1%
normal goat serum, cells were incubated with a Texas-red-
labeled goat anti-mouse antibody (Jackson Labs). All cov-
erslips were mounted on glass slides and imaged with a
fluorescent microscope (Leica DMR) and a charge-cou-
pled device camera (Leica DC200). For western blotting,
cells from 3 cm wells were harvested in Laemmli buffer
containing 6 M urea. 10 ug of total cellular protein was
loaded onto a 12% SDS-PAGE, then semi-dry blotted
onto Hybond C+ (Amersham) before blocking and incu-
bation with monoclonal anti-GFP antibodies (Boehring-
er).
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